Apeximmune Therapeutics
PrivateLast Round
Series A
Mar 31, 2025
Total Funding Raised
$27.7M
Company Overview
Apeximmune Therapeutics is a biotechnology company that develops novel biologics and therapeutic antibodies designed to modulate the immune system for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apeximmune Therapeutics Comparables
Compare Apeximmune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pheast Therapeutics | 83% | |
| Agni Bio, Inc. | 83% | |
| Immune-Onc Therapeutics | 83% | |
Apeximmune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2025 | ||||
| Grant | Jun 1, 2023 | ||||
| Seed | Mar 15, 2021 |
Apeximmune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| DCI Partners | Series A |
| TA YA VENTURE HOLDINGS LIMITED | Series A |
| Hercules Bioventure Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2025
$21.3M raised in Series A funding.
Apeximmune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apeximmune Therapeutics's valuation, stock price, and market status.